Clinical Trial Update: Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing everolimus with lower versus higher tacrolimus exposure in de novo kidney transplant patients, assessing safety, tolerability and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED